Ernexa Therapeutics Advances ERNA-101
Ernexa Therapeutics moves forward with ERNA-101, targeting Q3 IND filing. This development may impact the biotech sector.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.